Results: 20

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis

Ann. hepatol; 16 (2), 2017
ABSTRACT Background and aim. The combination of Sofosbuvir (SOF) and Ledipasvir (LDV) has been lead to considerable enhancement of treatment of hepatitis C virus (HCV) genotype 1 infection. A meta-analysis of the currently available studies was undertaken with the aim to evaluate the antiviral efficacy ...

Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma

Ann. hepatol; 16 (2), 2017
ABSTRACT HBV and HCV reactivation has been widely reported in patients undergoing immunosuppressive therapy for oncohaematological diseases. We aimed to evaluate the HBV and HCV reactivation events in patients with non-Hodgkin lymphoma (NHL) or Hodgkin lymphoma (HL) underwent cytotoxic chemotherapy conta...

Sofosbuvir and Daclatasvir in Mono-and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant

Ann. hepatol; 16 (1), 2017
Abstract: Background and aims. Pegylated interferon (Peg-INF) and ribavirin (RBV) based therapy is suboptimal and poorly tolerated. We evaluated the safety, tolerability and efficacy of a 24-week course of sofosbuvir plus daclatasvir without ribavirin for the treatment of hepatitis C virus (HCV) recurr...

Association of genotypes with viral load and biochemical markers in HCV-infected Sindhi patients

Braz. j. microbiol; 47 (4), 2016
Abstract The presented study had two objectives. The first was to examine distributions of Hepatitis C Virus (HCV) genotypes in Sindh, Pakistan, where HCV is prevalent. The other was to explore clinically relevant relationships between the genotypes, viral load (measured by real-time polymerase chain rea...

In-house quantitative real-time PCR for the diagnosis of hepatitis B virus and hepatitis C virus infections

Braz. j. microbiol; 47 (4), 2016
Abstract The quantification of viral nucleic acids in serum by real-time PCR plays an important role in diagnosing hepatitis B virus and hepatitis C virus infection. In this study, we developed an assay using specific primers and probes to quantify hepatitis B virus DNA or hepatitis C virus RNA in serum ...

An original method for producing acetaldehyde and diacetyl by yeast fermentation

Braz. j. microbiol; 47 (4), 2016
Abstract In this study a natural culture medium that mimics the synthetic yeast peptone glucose medium used for yeast fermentations was designed to screen and select yeasts capable of producing high levels of diacetyl and acetaldehyde. The presence of whey powder and sodium citrate in the medium along wi...

Presente y futuro de la terapia contra la hepatitis C

Invest. clín; 57 (1), 2016
Un 3% de la población mundial está infectado por el virus de la hepatitis C (VHC). Un 70-80% de los individuos infectados desarrollan una infección crónica. No se dispone de una vacuna contra la hepatitis C y aproximadamente 50% de los pacientes infectados no responden a la terapia estándar basada e...

Relationship between diversity of hepatitis C quasispecies and histological severity of liver disease

Medicina (B.Aires); 60 (5/1), 2000
The aim of this work to assess in the diversity of hepatitis C virus (HCV) quasispecies is related to histological severity and duration of infection in a cohort of untreated patients with an estimated onset of the disease. A total of 27 patients with diagnosis of chronic liver disease and history of blo...

Estudo clínico e sorológico da hepatite aguda näo-A näo-B em Salvador-Bahia

Introduçäo: O recente conhecimento das novas viroses hepatotrópicas, estimula o entendimento da história natural da hepatite induzida por estes agentes. Objetivos: Este estudo objetivou a investigaçäo clínica, bioquímica e sorológica, assim como a etiologia dos casos de hepatite aguda viral Näo...